SELECTION AND ANALYSIS OF SILENCING RNA FOR EFFICIENT DOWNREGULATION OF ENaC CHANNEL IN LUNG EPITHELIAL CELLS  by Tilesi, F. et al.
S16 Posters
CF cell line IB3−1 presented with increased GSTT1 and GSTM1 mRNA and
protein expression levels in comparison with the isogenic non-CF cell line C38.
AZM exposure signiﬁcantly decreased GSTT1 and GSTM1 mRNA and protein
expression in IB3−1, restoring the levels observed in C38 cells. In another CF cell
line, 2CFSMEo-, AZM produced 45% reductions in GSTT1 and GSTM1 mRNA
levels. The macrolide JM, known to lack clinical anti-inﬂammatory properties,
had no signiﬁcant effects on GSTT1 and GSTM1 mRNA expression in all cell
lines. GSTP1 was not differentially expressed in all CF and non-CF cells and its
expression was unaffected by AZM. AZM reduced GST activity of about 25% and
40% in IB3−1 and 2CFSMEo− cells, respectively.
Finally, GSTs activity and the expression of GSTT1 and GSTM1 proteins in
CF cells, were reduced by interleukin 10 (IL-10), an anti-inﬂammatory cytokine,
approximately to the same level detected after treatment with AZM, shedding light
on a possible correlation between GSTs inhibition and anti-inﬂammatory properties
of AZM.
Downregulation of GSTT1 and GSTM1 expression may result in increased avail-
ability of intracellular GSH making CF cells less susceptible to oxidative stress
induced by chronic inﬂammation. Thus these results suggest novel anti-oxidant
properties for AZM.
*CC and GB equally contributed to this work.
This study is supported by Italian CF Research Foundation (FFC10/2005; 17/2006);
Comitato di Vicenza-Associazione Veneta per la lotta contro la Fibrosi Cistica;
Azienda Ospedaliera Verona, Italy.
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Lung disease in cystic ﬁbrosis (CF) is characterized by excessive inﬂammation
and infection by several pathogens. The most relevant bacterium in CF is the
Pseudomonas (P.) aeruginosa that is able to colonize the CF airways by means
of its adaptation to the microaerobic environment.
Little is known about the changes in protein secretion induced by oxygen limitation
in PAO1, the proto-typical P. aeruginosa laboratory strain, and no data are available
on P. aeruginosa clinical strains, like AA2, used in this study. Our work was aimed
to study the differential regulation of proteins secreted by Pa strains grown in
microaerobic or aerobic conditions.
The set of polypeptides released by P. aeruginosa strains grown in microaerobic or
aerobic conditions were analyzed by two-dimensional capillary chromatography–
tandem mass spectrometry (MudPIT). We identiﬁed 75 polypeptides released by
PAO1 and 198 by AA2 strains grown in aerobic conditions. When the same strains
were cultured in microaerobic conditions we could identify 6 proteins up-regulated
and none down-regulated in PAO1 strain, while 4 proteins that were down-regulated
and 7 proteins up-regulated in AA2 strain. Among the peptides identiﬁed we found a
strong down modulation of alkaline metalloprotease peptides under microaerophilic
conditions by AA2 strain. The data were conﬁrmed by proteolytic activity assay
of the supernatants demonstrating that conditioned medium derived from AA2
grown in aerobic conditions has a much higher activity than the one obtained by
microaerophilic culture. Furthermore activity in PAO1-derived samples was barely
detectable and no such regulation was observed, indicating the functional relevance
of the data obtained by MudPIT analysis.
The identiﬁcation of virulence factors might be facilitated by this combined
approach that appears to be capable to restrict the number of potential candidates and
facilitate the identiﬁcation of molecular targets for pharmacological intervention.
*CC and GB equally contributed to this work.
This study is supported by Italian CF Research Foundation (FFC10/2005; 17/2006);
Comitato di Vicenza-Associazione Veneta per la lotta contro la Fibrosi Cistica;
Azienda Ospedaliera Verona, Italy.
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Cellular therapy of lung disease may be the resolutive cure for cystic ﬁbrosis (CF).
We investigated the effect of epithelial damage caused by Pseudomonas aeruginosa,
pathogenic bacterium widely occurring in CF patients, on the engraftment of bone
marrow (BM)-derived cells in pulmonary epithelium. Upon intratracheal injection
of total BM obtained from transgenic GFP-positive mice into P. aeruginosa-infected
mice, GFP-positive cells were found in the recepient lungs but their numbers were
very small. Only when bone marrow cells were puriﬁed by means of negative
immunoselection to obtain a cell suspension enriched in stem/progenitor cells
(20%, as evaluated by Sca1 expression), signiﬁcant numbers of GFP-positive
cells were detected in the lung epithelium. The fractions of GFP-positive cells
expressing cytokeratin were 0.34−0.76 %. To understand the cellular constraints
limiting homing of HSCs to the lung, we studied their energetic status and CFTR
expression. Confocal microscopy showed the high level of heterogeneity of the
mitochondrial content of these cells. To obtain a more homogeneously phenotypic
population, whole bone marrow was processed by through anti-Sca-1 positive
selection, which resulted in 80−90% HSCs. Cytoﬂuorimetric analysis revealed that
there were two different cell populations as regard to their size. Moreover, the
intracellular content of mitochondria was not homogeneously distributed in the Sca-
1+ cell population displaying a clear inverse correlation of their density with the
expression of the Sca-1 marker. Positively selected HSCs expressed CFTR protein,
as judged by epiﬂuorescence. Chloride secretion measurements at the single-cell
level and in the entire population demonstrated the presence of a functional
CFTR channel.
HSCs, due to their CFTR expression, could be useful in the treatment of CF by
means of bone marrow transplantation. It has ﬁrst to be seen which behaviour the
HSC sub-populations with different mitochondrial content displays in the homing
to the lung.
Supported by the EC grant QLRT 2002 02119 and Fondazione Italiana per la
Ricerca sulla Fibrosi Cistica (grant 2–2006).
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
P35 INFLUENCE OF PSEUDOMONAS AERUGINOSA ON THE
GROWTH RATE AND INTERNALIZATION OF BURKHOLDERIA
CENOCEPACIA
A. Bevivino2, L. Pirone1,2, S. Marinelli1, C. Auriche1, C. Dalmastri2,
F. Ascenzioni1. 1Dip. Biologia Cellulare e dello Sviluppo, Univ. “La Sapienza”,
Rome, Italy; 2Department of Biotechnologies, Agroindustry and Protection of
Health, ENEA C.R. Casaccia, Rome, Italy
Burkholderia cenocepacia is an important opportunistic pathogen among cystic
ﬁbrosis (CF) patients. The severity of infection has been related to a wide range
of potential virulence determinants and to the ability of B. cenocepacia bacteria to
invade respiratory epithelial cells and cause sepsis. Infection by these bacteria usu-
ally occurs in patients who are already colonized by Pseudomonas aeruginosa, the
major pathogen in CF. In order to understand the pathophysiology of B. cenocepacia
respiratory infections in CF, it is important to explore the interactions between the
different pathogens that may have synergic effects on their virulence. In the present
work, we aimed to determine whether P. aeruginosa PAO1 synergistically enhances
the growth rate and internalization of B. cenocepacia LMG16656T into human
epithelial cells. Results obtained from mixed cultures revealed no signiﬁcative
change in the B. cenocepacia growth rate, as compared to mono-culture data; on
the contrary, a signiﬁcant decrease of P. aeruginosa growth was observed. In a
co-infection assay, by using the pulmonary epithelial cell line A549, we found
a higher level of invasion by B. cenocepacia in the presence of P. aeruginosa as
compared to B. cenocepacia alone. Altogether, the results obtained strongly indicate
that pathogenic potential of B. cenocepacia may be enhanced by the co-presence
of P. aeruginosa that positively affects its internalization into human respiratory
epithelial cells, as well as by the growth inhibition of other pathogens, like
P. aeruginosa. Thus, the co-presence of two or more bacterial species in the lung of
CF patients may have a profound effect on the bacterial growth and internalization.
This work was supported by Italian Cystic Fibrosis Research Foundation (ffc),
Verona, Italy (FFC7–2006), and adopted by Delegazione FFC of Latina, Italy.
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Cystic ﬁbrosis (CF) lung disease is characterized by dehydration, followed by bac-
terial colonization, bronchiectasis and ultimately death. Assuming that reduction of
Na+ absorption could help to restore airway hydration, we planned to downregulate
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epithelial sodium channel (ENaC) by means of interferring RNAs and study the
functional consequences of this action. We have used two different approaches,
1) ENaC silencing on human H441 cells by using shRNAs, and 2) on human
primary bronchial epithelia via siRNAs. For the ﬁrst approach, we have selected
two RNA-mediated silencing targets for each of the three subunits, a, b and g of the
ENaC channel and assembled vectors for the production of shRNAs driven by polII-
dependent U1 promoter. Each construct has been subcloned into the episomal vector
pEPI and tested in bronchial H441 cells. From a screening in H441 cells we have
selected the A2 and B2 cassettes directed against the a and b subunits which yield
up to 70% and 40% reduction of the corresponding ENaC mRNA respectively.
The U1-A2 cassette was cloned in an integrating lentiviral vector, derived from
HIV-1. The transduction with this vector (aA2shRNA-LV) determined 40−50%
down-regulation of a ENaC mRNA in H441 cells and reduced also the amount of
b and g mRNA. aA2shRNA-LV efﬁcacy is being investigated in domes, ﬂuid-ﬁlled
hemicystis which are marker of ENaC localization to the cell membrane and formed
in H441 cells upon dexamethasone stimulation. LV infection of domes resulted in
only 0.6% of transduced cells, however LV efﬁciency rised to 92% when cells were
infected before dome appearance. For the second approach, we transfected pools
of commercial siRNA complementary to each of the three ENaC subunits and
measured the protein activity as the transepithelial short-circuit current on polarized
human bronchial epithelia. We found that sequences complementary to any of the
three subunits reduced the functional expression of ENaC, and that this effect lasted
several days. In conclusion, we believe that reduction of Na+ and water absorption
by using an iRNA approach against ENaC could be of beneﬁt to CF patients.
Work funded by the UE grant 005213 and Centro Regionale Fibrosi Cistica, Lazio,
Italy.
*This Poster has been presented also as Oral Communication, by invitation of
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Non-mammalian hosts, such as the nematode Caenorhabditis elegans, have recently
gained increasing attention as models for molecular pathogenesis studies. Advan-
tages of non-mammalian hosts include their ease of cultivation and short generation
times, as well as the availability of elaborate genetic, biochemical and cell biological
tools. Distinctive mechanisms of C. elegans killing have been deﬁned; among them
infection by many human pathogens, including Pseudomonas aeruginosa (Pa).
P. aeruginosa plays an important role in chronic lung infections among patients
with CF due to its ability to form bioﬁlm, which enables the bacteria to resist
treatments with antibiotics and which affects the actions of the cells of the immune
system.
The majority of P. aeruginosa virulence factors identiﬁed with C. elegans are also
required for virulence in amoebae, D. discoideum, D. melanogaster, plants and
mice; thus supporting the usefulness of the P. aeruginosa–C .elegans pathogenicity
model. When P. aeruginosa strain PA14 is grown on minimal medium, it slowly
kills C. elegans over the course of several days. This killing, called ‘slow killing’ to
differentiate it from toxin-mediated ‘fast killing’, correlates with the accumulation
of live bacteria within the nematode digestive tract.
We report data on the virulence capability of two different Pa isolates based on the
slow killing of C. elegans. One Pa strain was isolated from a CF patient at ﬁrst
colonisation, the other strain was collected from a chronically colonised patient.
We found a reduction in the virulence of the strain harboured by the chronically
colonised patient as compared with the strain collected at ﬁrst colonisation; this was
observed in all C. elegans strains analyzed, including the AU1 C. elegans strain
which harbours a mutation in the sek-1 gene, encoding a MAP kinase involved in
nematode innate immunity.
The reduction of virulence presumably reﬂects the adaptation to the chronic state in
the lungs of the patients. These results are in agreement with emerging evidences
indicating that the establishment of chronic P. aeruginosa infections in the CF lung
does not depend only on virulence factors.
Understanding the mechanisms of persistence of P. aeruginosa in C. elegans may
lead to the identiﬁcation and development of novel therapeutic targets and strategies
aimed at improving protection toward infections in CF patients.
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Introduction: Intestinal symptoms are frequently observed in patients with Cystic
Fibrosis (CF); pancreas insufﬁciency, however, does not provide a satisfactory ex-
planation for all of them. Some studies have showed chronic intestinal inﬂammation
in CF and Crohn disease is more frequent than in general population.
CAL is a calcium and zincum binding protein, belonging to S100 protein family,
that is released during neutrophil activation or death. Plasma CAL is used as an
inﬂammatory marker, while faecal concentration is used to detect intestinal disease.
As faecal marker, CAL is able to differentiate active inﬂammatory bowel disease
(IBD) from inactive as well from irritable bowel syndrome.
Plasma CAL concentration as a marker of pulmonary inﬂammation was tested in
children with CF and found to be a better index of pulmonary exacerbation than
the traditional indices.
The aim of this study is to validate faecal CAL as a non invasive marker of IBD
in CF patients.
Material and methods: Faecal and serum CAL was measured by enzyme-linked
immunosorbent assay in 20 CF patients (9 female and 11 male, mean 11.8 years,
range 7.5−18) attending at our Center. All patients were evaluated in clinically
stable condition as showed by clinic, Rx and biochemical examination.
Control population: 25 faecal samples from 7 IBD patients (2 females and 5 males
mean age 13 years range 13−19) and 10 faecal samples from 10 healthy subjects
(6 males and 4 females, mean age 11 years).
Results: 9/20 (45%) had high faecal CAL levels (> 200mg/kg.) and 3/9 patients
(33.3%) had CAL value > 300mg/kg; all the patients had normal plasmatic levels
(<1.6mg/kg).
Neither correlation between CAL and FEV1 (r: 0.197 P: 0.419), nor CAL and
steatorrhea (r: −0.313 P: 0.379) was found.
All patients with IBD had high faecal CAL values and endoscopic inﬂammation,
all healthy control had normal faecal CAL values (<25 mk/kg).
In CF patients mean faecal CAL values were higher than in healthy controls but
lower than in IBD patients.
Discussion: About 45% of CF patients tested had high faecal CAL levels, all of
them had no pulmonary exacerbations, supporting the idea that IBD is a frequent
feature in CF, as showed by the high prevalence of CD in CF patients. Our
preliminary data suggest that faecal CAL could be a non invasive marker of IBD in
CF and could be usefull to select patients to undergoing to invasive investigations.
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The respiratory tract of cystic ﬁbrosis (CF) patients provides a selective environment
favouring development and persistence of multiple P. aeruginosa pathogenic vari-
ants, that are not eradicable by any known therapy. P. aeruginosa genetic adaptation
is observed in chronic infections of CF patients in contrast to what it is documented
for acute infections. It is not yet known, whether P. aeruginosa clonal variants differ
in their pathogenic potential. A total of 40 clinical P. aeruginosa isolates from ten
CF patients, which carried unique clonal lineage from the onset of colonization over
4−18 years, were selected. Five P. aeruginosa environmental strains, which represent
the source of acquisition for CF patients, and two laboratory strains PAO1 and PA14
were used. Multiple genotypic analysis of sequential P. aeruginosa isolates which
included PFGE, ATchip and multilocus SNPs showed intraclonal diversity with
genome rearrangements, variations in pathogenic islands and acquisition of pro-
thoadaptive mutations in the muc genes and mutS, muL and uvrD genes of the mis-
match repair system. The largest divergence was observed between the completely
sequenced reference strains PAO1 and PA14, the latter represented in our panel by
three CF isolates. P. aeruginosa virulence of different clonal lineages was tested
for their ability to establish a chronic infection or to induce bacteremia in mice.
P. aeruginosa clonal strains differ signiﬁcantly in their virulence. Overall, P. aerug-
inosa clinical strains isolated after years of colonization increased signiﬁcantly
chronic persistence and reduced the risk of bacteremia when compared to strains iso-
lated at the onset of the infection or to those of environmental origin. Furthermore,
our data showed that P. aeruginosa adaptive traits generated in the CF lung, such as
the hypermutable phenotype, increased chronic persistence only in the presence of
antibiotic treatments. The results suggest that the unique genetic proﬁles of P. aerug-
inosa disease-associated isolates are correlated with different pathogenic potential.
Supported by Italian CF Research Foundation and Telethon.
